Home
>
National Drug Code (NDC)
>
Buprenorphine Hydrochloride
Buprenorphine Hydrochloride - 0517-0725-05 - (Buprenorphine Hydrochloride)
Drug Information of Buprenorphine Hydrochloride
| Product NDC: | 0517-0725 |
| Proprietary Name: | Buprenorphine Hydrochloride |
| Non Proprietary Name: | Buprenorphine Hydrochloride |
| Active Ingredient(s): | .324 mg/mL & nbsp; Buprenorphine Hydrochloride |
| Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Buprenorphine Hydrochloride
| Product NDC: | 0517-0725 |
| Labeler Name: | American Regent, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA078331 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20100813 |
Package Information of Buprenorphine Hydrochloride
| Package NDC: | 0517-0725-05 |
| Package Description: | 5 VIAL in 1 CARTON (0517-0725-05) > 1 mL in 1 VIAL (0517-0725-01) |
NDC Information of Buprenorphine Hydrochloride
| NDC Code | 0517-0725-05 |
| Proprietary Name | Buprenorphine Hydrochloride |
| Package Description | 5 VIAL in 1 CARTON (0517-0725-05) > 1 mL in 1 VIAL (0517-0725-01) |
| Product NDC | 0517-0725 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Buprenorphine Hydrochloride |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRAMUSCULAR; INTRAVENOUS |
| Start Marketing Date | 20100813 |
| Marketing Category Name | ANDA |
| Labeler Name | American Regent, Inc. |
| Substance Name | BUPRENORPHINE HYDROCHLORIDE |
| Strength Number | .324 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Partial Opioid Agonist [EPC],Partial Opioid Agonists [MoA] |
